VC-backed companies in China raised $6.7B (19% of global investment) in 2020. Biopharma leads other sectors with $3.4B invested, followed by dx/tools with $1.8B （Data Source: Silicon Valley Bank）
VC-backed companies have raised $4B+ on China’s public exchanges
In 2020, China has seen 18 companies IPO with a $1B+ market cap, led by the biopharma sector (Data Source: Silicon Valley Bank).
Macroeconomic forces have not inhibited cross-border activity.
In 2020, there has been an uptick in China-based investors participating in US and European deals (Data Source: Silicon Valley Bank).